ReviewTargeted oncology2026

Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?

Finn Segers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.